Literature DB >> 12185383

Presence of ductal carcinoma in situ confers an improved prognosis for patients with T1N0M0 invasive breast carcinoma.

A F Logullo1, A B Godoy, M Mourão-Neto, A J G Simpson, I N Nishimoto, M M Brentani.   

Abstract

We have retrospectively analyzed a series of 155 sequential cases of T1N0M0 ductal carcinomas of which 51 tumors had a ductal carcinoma in situ (DCIS) component for correlation between the presence of DCIS and clinicopathological variables, recurrence and patient survival. No correlations between the presence of DCIS and age, menopausal status, size, estrogen or progesterone receptors were found. High-grade infiltrative tumors tended not to present a DCIS component (P = 0.08). Patients with tumors associated with DCIS form a subgroup with few recurrences (P = 0.003) and good survival (P = 0.008). When tumors were classified by size, an association between large tumors (>1.0 cm) and increased recurrence and shortened overall survival was found. The presence of DCIS in this subgroup significantly reduced the relative risk of death.

Entities:  

Mesh：

Year:  2002        PMID： 12185383     DOI： 10.1590/s0100-879x2002000800008

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN： 0100-879X            Impact factor:   2.590


  6 in total

1.  Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses.

Authors:  Melanie Ruszczyk; Gary Zirpoli; Shicha Kumar; Elisa V Bandera; Dana H Bovbjerg; Lina Jandorf; Thaer Khoury; Helena Hwang; Gregory Ciupak; Karen Pawlish; Pepper Schedin; Patricia Masso-Welch; Christine B Ambrosone; Chi-Chen Hong
Journal:  Cancer Causes Control       Date:  2015-11-30       Impact factor: 2.506

2.  The prognostic significance of co-existence ductal carcinoma in situ in invasive ductal breast cancer: a large population-based study and a matched case-control analysis.

Authors:  Hongliang Chen; Fang Bai; Maoli Wang; Mingdi Zhang; Peng Zhang; Kejin Wu
Journal:  Ann Transl Med       Date:  2019-09

3.  Prognostic value of ductal carcinoma in situ component in invasive ductal carcinoma of the breast: a Surveillance, Epidemiology, and End Results database analysis.

Authors:  San-Gang Wu; Wen-Wen Zhang; Jia-Yuan Sun; Zhen-Yu He
Journal:  Cancer Manag Res       Date:  2018-03-19       Impact factor: 3.989

4.  Prognostic value of integrin αV expression and localization pattern in invasive breast carcinomas.

Authors:  Otto Luiz Dutra Cerqueira; Mayara Carolline Silva Botelho; Ana Paula Zen Petisco Fiore; Cynthia Aparecida Bueno de Toledo Osório; Rebeka Tomasin; Mauro César Cafundó Morais; Rossana Verónica Mendoza López; Elaine Cristina Cardoso; Santiago Andres Vilella-Arias; Eduardo Moraes Reis; Alexandre Bruni-Cardoso
Journal:  Neoplasia       Date:  2022-05-05       Impact factor: 6.218

5.  Does concomitant ductal carcinoma in situ affect the clinical outcome in breast cancer patients with invasive ductal carcinoma: An Asian perspective.

Authors:  Wai Peng Lee; Spoorthi Sudhakar Shetty; Chin Mui Jaime Seah; Pei Ting Tan; Su Ming Tan
Journal:  Cancer Rep (Hoboken)       Date:  2022-07-26

6.  Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS?

Authors:  Ismet Sarikaya; Ali Sarikaya; Ahmed N Albatineh; Ebru Tastekin; Yavuz Atakan Sezer
Journal:  Asia Ocean J Nucl Med Biol       Date:  2020
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.